negative side effects of glp 1 agonists Relative glucagon-like peptide-1 (GLP-1) vs Safety and Tolerability of Glucagon-Like

Most resolve within 4-6 weeks

The First Wave: Older GLP-1 Medications Before semaglutide stole the spotlight, several other GLP-1 agonists were used primarily for diabetes management, with modest weight loss benefits

Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation

Faillie et al

The GLP-based therapies used during the weight loss intervention included semaglutide (86%), tirzepatide (48%), liraglutide (21%), and dulaglutide (14%), with patients switching between these agents on the basis of insurance coverage and/or medication availability

See more Eye drops containing beta-blockers are prohibited in particular sports under section P1 because the ophthalmic administration of beta-blockers results in systemic concentrations of the drugs similar to when the medication is taken orally